Prognostic Significance of NSCLC and Response to EGFR-TKIs of EGFR-Mutated NSCLC Based on PD-L1 Expression

Kobayashi, K; Seike, M; Zou, FF; Noro, R; Chiba, M; Ishikawa, A; Kunugi, S; Kubota, K; Gemma, A

Seike, M (reprint author), Nippon Med Sch, Grad Sch Med, Dept Pulm Med & Oncol, Tokyo 1138603, Japan.

ANTICANCER RESEARCH, 2018; 38 (2): 753

Abstract

Background/Aim: Recent clinical trials have shown that immune checkpoint blockades that target either PD-1 or PD-L1 yield remarkable responses in a su......

Full Text Link